Based on previous studies done in mice, researchers observed that GLP-1 agonists/DPP-4 inhibitors work to reduce inflammation in the gut, so they proposed that the same mechanism may occur in humans (5, 6)
Unimolecular peptides with dual GIP/GLP-1 receptor agonism have been developed to improve metabolic efficacy and therapeutic index beyond what incretin mono-agonists can achieve (44, 63)
However, theres a newer medication called Mounjaro (tirzepatide), which acts on both GLP-1 and GIP receptors, offering even more powerful results for managing blood sugar and promoting weight loss
As word of mouth spread, the natural health industry developed and Nutri Advanced began to win the trust of practitioners across the country
They include leucine, isoleucine, and valine